Investments
25Portfolio Exits
1
Want to inform investors similar to China Life Equity Investment about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
China Life Equity Investment Investments
25 Investments
China Life Equity Investment has made 25 investments. Their latest investment was in VJTBIO as part of their Series C on May 5, 2023.
China Life Equity Investment Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/22/2023 | Series C | VJTBIO | Yes | 3 | ||
3/9/2023 | Series C | SVision | Yes | 3 | ||
1/9/2023 | Series D | Marching Power | Yes | 3 | ||
12/12/2022 | Private Equity | |||||
12/9/2022 | Series C |
Date | 5/22/2023 | 3/9/2023 | 1/9/2023 | 12/12/2022 | 12/9/2022 |
|---|---|---|---|---|---|
Round | Series C | Series C | Series D | Private Equity | Series C |
Company | VJTBIO | SVision | Marching Power | ||
Amount | |||||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 3 | 3 | 3 |
China Life Equity Investment Portfolio Exits
1 Portfolio Exit
China Life Equity Investment has 1 portfolio exit. Their latest portfolio exit was Biocytogen on September 01, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/1/2022 | IPO | Public | 1 |
Date | 9/1/2022 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | Public |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.